U.S. Markets closed

Pfizer delivers Phase 3 test results for COVID-19 vaccine to Brazil regulator

RIO DE JANEIRO, Dec 16 (Reuters) - Pfizer Inc has delivered the results of the Phase 3 trial for its COVID-19 vaccine to Brazilian health regulator Anvisa, the regulatory body said in a statement on Wednesday.

Pfizer is the second company to do so after AstraZeneca Plc delivered its results to Anvisa earlier in December. (Reporting by Pedro Fonseca Writing by Gram Slattery Editing by Brad Haynes)